Thematic Take

Powered by

Cyrus Mewawalla, Head of Thematic Intelligence, GlobalData

Foreword: unlocking robotics’ full potential 

At GlobalData, we define a theme as any issue that keeps a business leader awake at night. 

Companies are impacted by multiple themes that frequently conflict with one another. What is needed is an effective methodology that reflects, understands, and reconciles these conflicts. 

Our thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. 

Viewing the world’s data by themes makes it easier to make critical decisions. Companies that invest in the right themes become success stories. Those that miss the essential themes in their industry end up as failures. 

Robotics has a long history, but only relatively recently have conditions aligned to unlock its full potential. Those conditions are technological, economic, and demographic: 

  • Cloud computing and artificial intelligence (AI) enable robots to collaborate and access huge amounts of data uninterruptedly. 
  • Automation is key to improving productivity across various sectors, including healthcare, manufacturing, and logistics. 
  • Societies are using robots to care for older people and address shortages in the workforce. 

Science fiction often speculates about robots that are virtually indistinguishable from humans. Yet, the most popular consumer robot is still a vacuum cleaner shaped like a disc. In factories and warehouses, human staff work alongside robots that are incredibly good at performing repetitive and dangerous tasks but do not look or behave like humans.  

In the future, AI will allow robots to identify human emotions, and the field of soft robotics is developing robots from materials similar to those found in living organisms. There is a chance that one day, life will imitate art, and robots will look like people. If and when that happens, societies will face an ethical conundrum: what rights do we give non-human creatures that look like us? 

Go to article: Home | Digital dilemma in UK life sciences job marketGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: DatwylerGo to article: CytivaGo to article: bioMérieux Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: PfanstiehlGo to article: SyntegonGo to article: In DepthGo to article: UK life sciences grapple with the job market’s digital dilemma Go to article: Telemedicine struggles to overcome diversity challenges in dermatology trials Go to article: Cancer treatment uncertainty: European nations struggle with drug shortages Go to article: From Europe to Latin America: Driving access to affordable biosimilars Go to article: Q&A: How the Henrietta Lacks settlement challenges biotech's view on ethics Go to article: Generative AI has the potential to revolutionise drug discovery Go to article: European PFAS ban would burden drug companies and packagers Go to article: Molnar-Institute Company InsightGo to article: Molnar-InstituteGo to article: Thematic TakeGo to article: Thematic Take: contentsGo to article: Foreword: unlocking robotics’ full potential Go to article: An introduction to robotics Go to article: A history of robotics  Go to article: The impact of robotics on the healthcare sector Go to article: Case studies: robotics in the pharmaceutical industry Go to article: Latest news: robotics in pharmaGo to article: Robotics: transforming cell and gene therapy manufacturingGo to article: Robotics innovation: Leading companies in microneedles for transdermal drug delivery Go to article: Deal activity related to robotics in the pharmaceutical industry since 2020 Go to article: Robotics hiring trends in the global pharmaceutical industry since 2020 Go to article: Robotics patent applications in the global pharmaceutical industry since 2020 Go to article: Mentions of robotics in pharmaceutical industry company filings since 2020 Go to article: GlobalData Thematic IntelligenceGo to article: Sponsored SupplementsGo to article: NiproGo to article: Watson MarlowGo to article: ListingsGo to article: EventsGo to article: AwardsGo to article: Buyer's GuidesGo to article: Next issue